Back to Top Skip to main content Skip to sub-navigation

Partnerships, COVID-19 are catalysts for enterprise virtual health

Image of Mr. Adler with text: "Partnerships, COVID-19 are catalysts for enterprise virtual health." Jamie Adler is the lead for the DHA’s Virtual Health Clinical Integration Office, part of the DHA Connected Health Branch, under DHA Medical Affairs. (Graphic courtesy of DHA Connected Health.)

Recommended Content:

Coronavirus | Connected Health | COVID-19 Vaccine Toolkit

In the pre-COVID-19 world, nearly all health care was delivered in person within brick-and-mortar facilities. Telehealth, referred to in the Department of Defense as virtual health or VH, was a promise of the future—a capability whose time had not quite yet arrived. VH, in those pre-pandemic days, and years, was relegated to pilot demonstrations and to specific specialties such as behavioral health delivered in limited settings.

As with so many other things, the COVID-19 pandemic wiped away long-held health care delivery practices and assumptions. Questions stopped being about if or even when VH would “take off” and started to be about how to maximize VH’s scope and reach in as short of a timeframe as possible. Mirroring the rest of the health care field, DOD rapidly scaled up VH capabilities, guidance, training, procedures, and provider and beneficiary communication and education. Over a period of weeks, the result was a multi-fold increase in overall VH capacity that supported basic clinical services across the DOD enterprise.

From a VH perspective, the pre-COVID-19 world is likely gone. VH as a core health care capability is here to stay. The Military Health System’ path forward can build upon COVID-19 and pre-existing efforts to develop enterprise VH capabilities that connect service members and their families to optimal health care—wherever and whenever it is needed.

To achieve this goal, it is important to realize that VH is not a single technology or business platform, or even group of platforms. Rather, it is about people, processes, and technologies working together across the entire MHS to create health care access solutions on behalf of our 9.6 million beneficiaries around the world.

The MHS is leveraging the experiences and workflows developed rapidly in response to COVID-19 to catalyze transformational change in enterprise use of VH. Coordination among multiple key stakeholders is essential and already underway to develop sustainable solutions that meet real MHS-wide needs.

These stakeholders include:

  • The newly emerging Defense Health Agency markets—regional clusters of MHS military medical treatment facilities
  • An enterprise-wide Virtual Medical Center
  • A variety of DHA headquarters offices, including the DHA Connected Health Branch’s Virtual Health Clinical Integration Office
  • The TRICARE private sector care network
  • The military services and interagency partners such as the Department of Veterans Affairs

Many Systems into One

For years, service-based enterprise and regional health care leaders and military medical treatment facilities (MTFs) spearheaded individual initiatives that built useful VH capabilities in a number of locations across the MHS. This approach, however, resulted in fragmented availability of VH capabilities across the more than 700 MTFs constituting the MHS. In addition, the TRICARE private sector care network permitted VH care only under limited circumstances.

In the 2017 National Defense Authorization Act, Congress required the DOD to expand VH across a wide spectrum of services and specialties, and across all direct (MTF-based) care and private sector care networks. Furthermore, Congress required that this VH expansion occur within the context of a consolidation and unification of non-deployed health care under the DHA. Since then, the DHA, the services, and their stakeholders have been working to prioritize, fund, and deliver integrated enterprise VH capabilities to medical centers and clinics, patient locations in the community, and settings in the field.

These efforts have one goal: create an integrated, comprehensive, high-quality, and reliable VH capability that reaches from forward deployment to fixed medical facilities, community settings, and to DOD partners such as the VA. The effect of the COVID-19 pandemic, as profound as it has been, was to greatly accelerate a process of enterprise VH expansion that is already ongoing.

Success of this endeavor would provide field units, clinics, inpatient facilities, managed care network providers, and virtual providers with the flexibility to meet patient needs regardless of location, while leveraging enterprise-wide competency, technical, procedural, and quality standards. This capability will turn VH into a powerful force multiplier for the MHS, delivering great health outcomes, support for a ready medical force, and enhanced beneficiary satisfaction. By increasing provider and support staff reach, capability, and effectiveness, VH will also help with the DHA’s goal of a fulfilled staff.

Looking Ahead

The COVID-19 pandemic is still testing MHS’ ability to use existing tools, training, and procedures to mount an aggressively accelerated deployment of VH capabilities. As we envision post-pandemic growth of virtual health, the MHS will need to continue to expand VH capabilities across its enterprise, while planning for the comprehensive and integrated tools and approaches that will make such growth sustainable in the long term.

Fielding any technology-based capability—including virtual health—takes a lot of pre-planning, collaboration, and effort. The development, acquisition, and sustainment of VH platforms across the MHS enterprise is an especially complex undertaking.

The MHS has many requirements beyond those followed by the non-DoD health care industry. In addition to providing safe, convenient, quality services, MHS VH must support military readiness and deployed health care, while operating within an environment of enhanced government regulation and heightened security. Meeting these requirements necessitates planning for all appropriate contingencies, including natural and man-made disasters and global emergencies such as the COVID-19 pandemic.

The results of these efforts, on the part of the MHS and its partners will be a virtual health capability that provides universal and global access to high-quality care and consultation to all beneficiaries, regardless of location or circumstance. This future state will be worth the effort for providers, and most importantly for patients, during the COVID-19 pandemic and beyond.

You also may be interested in...

Get to Know the Vaccines

Publication
9/17/2021

A graphic showing the types of vaccines, how they work, and safety monitoring of the vaccines. Includes the MHS and TRICARE logos on the bottom right, and includes graphics of scientists, doctors, and patients.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines

Get to know the COVID19 Vaccines

Publication
9/17/2021

Get to know the vaccines – they do not contain the live virus, they do not interact with our DNA, and have been tested rigorously.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines

Line Leader Presentation (PDF)

Publication
8/4/2021

This document is identical to the PowerPoint presentation for line leader reference and use.

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Line Leader Presentation (Powerpoint)

Publication
8/4/2021

Leaders across the Department can leverage this briefing deck to discuss COVID-19 vaccines with their troops. Don't forget to reference speaker notes and to personalize the title slide!

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

VAX Facts about Getting the COVID Vaccine at the Same Time as Others

Publication
6/9/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

Get to Know the COVID-19 Vaccines

Publication
6/9/2021

The Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) COVID-19 vaccines were developed to prevent infection from the virus that causes COVID-19.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

Get to Know the COVID-19 Vaccines (Combined)

Publication
6/9/2021

The Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) COVID-19 vaccines were developed to prevent infection from the virus that causes COVID-19. Learn about the vaccines, how they work and safety precautions.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | Getting the COVID-19 Vaccine | COVID-19 Vaccine Efforts

How COVID-19 Vaccines Work

Publication
6/9/2021

Learn how the different COVID-19 vaccines work.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

COVID-19 Vaccine Safety Monitoring

Publication
6/9/2021

The FDA and CDC continue to monitor the safety of COVID-19 vaccines. CDC has an independent group of experts that reviews all the safety data as it comes in and provides regular safety updates.

Recommended Content:

Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Toolkit | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

COVID-19 Vaccine Leader Card

Publication
5/27/2021

This printable card provides talking points when discussing the COVID-19 vaccine with servicemembers who are reluctant or indifferent to accepting the vaccine. The card lists common concerns and impressions, top 5 key messages, and supporting facts about the vaccine.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

Unit Leader Vaccine Conversation Guide

Publication
5/24/2021

This guide offers approaches and illustrative examples for preparation, delivery, and navigation of small group discussions (recommended 1-5 people to facilitate greatest engagement) with servicemembers reluctant or indifferent to accepting the vaccine. The guide promotes an open dialogue regarding vaccine hesitancy and complacency by addressing concerns, building trust, and boosting vaccine confidence.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

Provider Vaccine Conversation Guide

Publication
5/24/2021

This guide offers approaches and illustrative examples for Military Health System (MHS) providers to discuss the COVID-19 vaccine with servicemembers during routine visits. Initiating a COVID-19 vaccine conversation during servicemember visits will allow you to effectively address concerns, build trust, and boost vaccine confidence.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

COVID-19 Vaccine Approved for Adolescents Ages 12 and Over

Publication
5/13/2021

The Pfizer-BioNTech vaccine is approved for those ages 12 and over. Includes a photo of adolescents at the top of the page, has the TRICARE logo at the bottom right. Links in the content include www.TRICARE.mil/VaccineAppointments and www.Vaccines.gov.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Eligibility

VAX Facts about Breastfeeding

Publication
4/21/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

VAX Facts How Long does Protection Last?

Publication
4/21/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 7

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.